{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.6","upperLimit":"5","value":"1.4"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"63"}],"units":"Participants"}],"description":"Time from documentation of first response to progressive disease.","dispersionType":"95% Confidence Interval","groups":[{"description":"bortezomib and rituximab\n\nBortezomib: Once weekly for 3 weeks\n\nRituximab: Intravenously once a week for the first and fourth weeks of a cycle","id":"OG000","title":"Bortezomib and Rituximab"}],"paramType":"MEDIAN","populationDescription":"All participants enrolled","reportingStatus":"POSTED","timeFrame":"5 Years","title":"Duration of Response in Patients With WM","type":"SECONDARY","unitOfMeasure":"years"}